GLCCI1 Variation Is Associated with Asthma Susceptibility and Inhaled Corticosteroid Response in a Chinese Han Population

Archives of Medical Research

Volumn 47, Issue 2, 2016, Pages 118-125

  Hu, Chengping ^a   Xun, Qiufen ^a   Li, Xiaozhao ^a   He, Ruoxi ^a   Lu, Rongli ^a   Zhang, Shichuan ^a   Hu, Xinyue ^a   Feng, Juntao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asthma susceptibility; Corticosteroid; Glucocorticoid induced transcript 1 gene; Heterogeneity; Single nucleotide polymorphisms

Indexed keywords

FLUTICASONE PROPIONATE; MESSENGER RNA; SALBUTAMOL; BRONCHODILATING AGENT; FLUTICASONE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID-INDUCED TRANSCRIPT 1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; ASTHMA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENOTYPE; GLUCOCORTICOID INDUCED TRANSCRIPT 1 GENE; HAN CHINESE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; DISEASE PREDISPOSITION; ETHNOLOGY; GENETIC ASSOCIATION STUDY; GENETICS; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED;

ADMINISTRATION, INHALATION; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; FLUTICASONE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCOCORTICOID;

EID: 84973879905     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2016.04.005     Document Type: Article

References (33)

1. To T., Stanojevic S., Moores G., et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012, 12:204.
2. Drazen J.M., Silverman E.K., Lee T.H. Heterogeneity of therapeutic responses in asthma. Br Med Bull 2000, 56:1054-1070.
3. Szefler S.J., Martin R.J., King T.S., et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002, 109:410-418.
4. Jang A.S., Lee J.H., Park S.W., et al. Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma. Chest 2005, 128:1140-1145.
5. Pignatti P.F. Trends in pharmacogenomics of drugs used in the treatment of asthma. Pharm Res 2004, 49:343-349.
6. Malmstrom K., Rodriguez-Gomez G., Guerra J., et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999, 130:487-495.
7. Palmer L.J., Silverman E.S., Weiss S.T., et al. Pharmacogenetics of asthma. Am J Respir Crit Care Med 2002, 165:861-866.
8. Tantisira K.G., Lasky-Su J., Harada M., et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 2011, 365:1173-1183.
9. Chapman M.S., Askew D.J., Kuscuoglu U., et al. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells. Mol Endocrinol 1996, 10:967-978.
10. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Published 2012. http://www.ginasthma.org.
11. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
12. Liu M., Rogers L., Cheng Q., et al. Genetic variants of TSLP and asthma in an admixed urban population. PLoS One 2011, 6:e25099.
13. Noguchi E., Sakamoto H., Hirota T., et al. Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet 2011, 7:e1002170.
14. Anantharaman R., Andiappan A.K., Nilkanth P.P., et al. Genome-wide association study identifies PERLD1 as asthma candidate gene. BMC Med Genet 2011, 12:170.
15. Acevedo N., Sääf A., Söderhäll C., et al. Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma. PLoS One 2013, 8:e60111.
16. Jiménez-Morales S., Martínez-Aguilar N., Gamboa-Becerra R., et al. Polymorphisms in metalloproteinase-9 are associated with the risk for asthma in Mexican pediatric patients. Hum Immunol 2013, 74:998-1002.
17. Miyake Y., Tanaka K., Arakawa M. Relationship between polymorphisms in IL4 and asthma in Japanese women: the Kyushu Okinawa Maternal and Child Health Study. J Investig Allergol Clin Immunol 2013, 23:242-247.
18. Radhakrishnan A.K., Raj V.L., Tan L.K., et al. Single nucleotide polymorphism in the promoter of the human interleukin-13 gene is associated with asthma in Malaysian adults. Biomed Res Int 2013, 2013:981012.
19. Perin P., Berce V., Potocnik U. CD14 gene polymorphism is not associated with asthma but rather with bronchial obstruction and hyperreactivity in Slovenian children with non-atopic asthma. Respir Med 2011, 105(suppl 1):S54-S59.
20. Jie Z., Hu Z., Bai C., et al. ADAM33 gene polymorphisms associate with asthma susceptibility and severity in East China Han population. J Asthma 2011, 48:979-985.
21. Ober C., Tan Z., Sun Y., et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008, 358:1682-1691.
22. van Dienmen C.C., Postma D.S., Vonk J.M., et al. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005, 172:329-333.
23. Simpson A., Custovic A., Tepper R., et al. Genetic variation in vascular endothelial growth factor-a and lung function. Am J Respir Crit Care Med 2012, 185:1197-1204.
24. Li X., Hawkins G.A., Ampleford E.J., et al. Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. J Allergy Clin Immunol 2013, 132:313-320.
25. Blake K.V., Madabushi R., Derendorf H., et al. Population phamacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma. Chest 2008, 134:981-989.
26. Lima J.J. Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers. Mol Diagn Ther 2007, 11:97-104.
27. Kazani S., Wechsler M.E., Israel E. The role of pharmacogenomics in improving the management of asthma. J Allergy Clin Immunol 2010, 125:295-302.
28. Israel E. Genetics and the variability of treatment response in asthma. J Allergy Clin Immunol 2005, 115(4 suppl):S532-S538.
29. Hosking L., Bleecker E., Ghosh S., et al. GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma. J Allergy Clin Immunol 2014, 133:587-589.
30. Vijverberg S.J., Tavendale R., Leusink M., et al. Pharmacogenetic analysis of GLCCI1 in three north European pediatric asthma populations with a reported use of inhaled corticosteroids. Pharmacogenomics 2014, 15:799-806.
31. Al-Muhsen S., Vazquez-Tello A., Jamhawi A., et al. Rs37972 and rs37973 single-nucleotide polymorphisms in the glucocorticoid-inducible 1 gene are not associated with asthma risk in a Saudi Arabian population. J Asthma 2015, 52:115-122.
32. Izuhara Y., Matsumoto H., Kanemitsu Y., et al. GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids. Allergy 2014, 69:668-673.
33. Leung T.F., Ko F.W., Sy H.Y., et al. Differences in asthma genetics between Chinese and other populations. J Allergy Clin Immunol 2014, 133:42-48.